Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Cancer

• Publication date

  1982-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19821101)50:9<1695::AID-CNCR2820500907>3.0.CO;2-HPMID 6749279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-Hodgkin’s Lymphomas

  1999cited by this paper
• Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant.

  1981cited by this paper
• Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.

  1980cited by this paper
• Prognostic significance of serum lactate dehydrogenase in malignant lymphoma

  1980cited by this paper
• The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.

  1980cited by this paper
• Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma.

  1979cited by this paper
• Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.

  1979cited by this paper
• Non-Hodgkin's lymphomas: a clinicopathologic study comparing two classifications.

  1978cited by this paper
• Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma.

  1978cited by this paper
• Diffuse histiocytic lymphoma involving the gastrointestinal tract

  1978cited by this paper
• Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

  1978cited by this paper
• Immunodeficiency in patients with non-Hodgkin lymphomas.

  1977cited by this paper
• Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.

  1977cited by this paper
• Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

  1976cited by this paper
• Letter: Combined therapy for small-cell carcinoma of the bronchus.

  1976cited by this paper
• Central nervous system complications in patients with diffuse histiocytic and undifferentiated lymphoma: leukemia revisited.

  1976cited by this paper
• The effect of sex hormones on the growth of HeLa tumour nodules in male and female mice.

  1975cited by this paper
• New approaches to the classification of the lymphomata.

  1975cited by this paper
• Advanced diffuse histiocytic lymphoma, a potentially curable disease.

  1975cited by this paper
• Failure to detect antibody against Gross virus in tetraparental AKR reversible CBA mouse chimaeras.

  1975cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper
• An improved automated procedure for the determination of calcium in biological specimens.

  1967cited by this paper
• The automated determination of NAD-coupled enzymes. II. Serum lactate dehydrogenase.

  1966cited by this paper
• Tumors of the hematopoietic system

  1966cited by this paper

• United States Patent ( 10 ) Patent No . : US 7 , 381 , 560 B 2

  2017cites this paper
• Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

  2012cites this paper
• Enteropathy-type T-cell lymphoma occurring in the colon

  2008cites this paper
• A Marked Increase in Myeloblasts in the Peripheral Blood of a Patient with Burkitt Lymphoma following Granulocyte Colony-Stimulating Factor Administration

  2008cites this paper
• VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

  2007cites this paper
• Review article: stem cell transplantation for the treatment of gastrointestinal diseases – current applications and future perspectives

  2007cites this paper
• Toxicity and preliminary results with a new eight‐drug regimen (CEOP‐IMVP‐DEXA) in the treatment of aggressive lymphomas

  2006cites this paper
• Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma

  2006cites this paper
• Long-term results of dose density therapy in patients with aggressive lymphoma

  2005cites this paper
• MACOP-B Chemotherapy for the treatment of high grade and intermediate grade Non Hodgkin's lymphoma

  2005cites this paper
• Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non‐Hodgkin lymphoma

  2005cites this paper
• Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.

  2004cites this paper
• A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma — intensive two-phase chemotherapy

  2004cites this paper
• Linfomas no hodgkinianos de presentación sistémica e infección por VIH

  2004cites this paper
• Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)

  2004cites this paper
• Non-Hodgkin’s Lymphoma

  2003cites this paper
• Enteropathy-Type I ntestinal T -Cell L ymphoma: C linical Features a nd T reatment o f 3 1 P atients i n a S ingle C enter

  2000cites this paper
• Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone): 25-year experience.

  2000cites this paper
• Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.

  2000cites this paper
• Granulocyte-Colony Stimulating Factor (G-CSF) May Improve Disease Outcome in Elderly Patients with Diffuse Large Cell Lymphoma (DLCL) Treated with CHOP Chemotherapy

  2000cites this paper
• The management of adult aggressive non-Hodgkin's lymphomas.

  2000cites this paper
• A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.

  2000cites this paper
• COPBLAM/MEVMP REGIMEN FOR INTERMEDIATE-GRADE NON-HODGKIN'S LYMPHOMA

  2000cites this paper
• Inhibition of p34cdc2 dephosphorylation in DNA damage‐ and topoisomerase II inactivation‐induced G2 arrests in HL‐60 cells

  1999cites this paper
• Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center.

  1998cites this paper
• LINFOMAS NO HODGKIN EN LA PROVINCIA DE SANTA CRUZ DE TENERIFE

  1998cites this paper
• Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.

  1997cites this paper
• Bone marrow involvement, in intensively treated patients with intermediate grade non-Hodgkin's lymphoma, is a risk factor for granulocytopenia and fever.

  1996cites this paper
• CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.

  1996cites this paper
• Results of Treatment for non-Hodgkin's Lymphoma of the Head and Neck.

  1996cites this paper
• Diffuse histiocytic lymphoma treated with chemotherapy and radiation.

  1996cites this paper
• Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation.

  1996cites this paper
• [Non-Hodgkin's lymphomas associated with the acquired immunodeficiency syndrome. A multicenter clinical study of 77 cases].

  1995cites this paper
• Chylothorax in lymphoma: mechanisms and management.

  1995cites this paper
• [Research on prognostic factors in large-cell lymphomas].

  1995cites this paper
• A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.

  1995cites this paper
• Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.

  1995cites this paper
• Flow cytometric measurement of proliferation‐associated nuclear antigen p105 and DNA content in immuno‐proliferative small intestinal disease (IPSID)

  1995cites this paper
• The importance of dose and schedule in cancer chemotherapy: haematological cancer

  1995cites this paper
• CHOP chemotherapy of intermediate and high-grade non-Hodgkin's lymphoma.

  1994cites this paper
• Autoreactive T cell-dependent polyclonal hypergammaglobulinemia in mantle cell lymphoma.

  1994cites this paper
• Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphoma.

  1994cites this paper
• Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.

  1994cites this paper
• Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

  1994cites this paper
• Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35).

  1994cites this paper
• A six-drug regimen (MAPECO) for intermediate or high-grade non-Hodgkin's lymphoma.

  1994cites this paper
• Large cell non-Hodgkin lymphoma of childhood: clinical characteristics and outcome.

  1994cites this paper
• High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation.

  1994cites this paper
• Prognostic factors in intermediate high grade lymphoma.

  1993cites this paper
• Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.

  1993cites this paper
• Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients.

  1993cites this paper
• Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.

  1993cites this paper
• Successful application of a previously derived prognostic index in the analysis of a randomised trial of 281 patients with high grade non-Hodgkin's lymphoma (HIGNHL).

  1993cites this paper
• Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems.

  1993cites this paper
• Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.

  1993cites this paper
• [Highly malignant non-Hodgkin's lymphomas].

  1993cites this paper
• Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.

  1993cites this paper
• Prognostic significance of clinical and pathologic features in diffuse large B‐cell lymphoma

  1993cites this paper
• Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.

  1992cites this paper
• Role of Mitoxantrone, High-Dose Cytosine Arabinoside, and Recombinant Human GM-CSF in Aggressive Non-Hodgkin’s Lymphoma

  1992cites this paper
• Non-Hodgkin-Lymphome

  1992cites this paper
• Anthracycline Containing Regimens in Intermediate Grade Lymphoma

  1992cites this paper
• Glucocorticoids in clinical oncology.

  1992cites this paper
• Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.

  1992cites this paper
• MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study.

  1992cites this paper
• Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.

  1991cites this paper
• Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

  1991cites this paper
• A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.

  1991cites this paper
• Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).

  1991cites this paper
• Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group.

  1991cites this paper
• Stage II large B-cell lymphoma with sclerosis treated with MACOP-B.

  1991cites this paper
• The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.

  1991cites this paper
• Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features.

  1991cites this paper
• Diffuse "histiocytic" lymphoma.

  1991cites this paper
• Clinical significance of morphologic subdivision in diffuse large cell lymphoma

  1991cites this paper
• Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment.

  1990cites this paper
• Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.

  1990cites this paper
• Mitoxantrone/high‐dose ara‐c and recombinant human gm‐csf in the treatment of refractory non‐hodgkin's lymphoma a pilot study

  1990cites this paper
• Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma.

  1990cites this paper
• Pirarubicin, A Novel Derivative of Doxorubicin THP‐COP Therapy for Non‐Hodgkin's Lymphoma in the Elderly

  1990cites this paper
• Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

  1990cites this paper
• Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.

  1990cites this paper
• Large-cell lymphomas: clinical and prognostic features.

  1990cites this paper
• CAVBP/DEP alternating chemotherapy for the treatment of intermediate and high grade non Hodgkin's lymphoma: Final results of a pilot study

  1990cites this paper
• Group risk classification of non-Hodgkin's lymphoma.

  1990cites this paper
• MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.

  1990cites this paper
• Non-Hodgkin's lymphoma. A four-drug regimen suitable for elderly patients with advanced disease.

  1990cites this paper
• Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.

  1989cites this paper
• Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy?

  1989cites this paper
• Autologous bone marrow transplantation. Current status and future directions.

  1989cites this paper
• Autologous bone-marrow transplantation in non-Hodgkin's lymphomas.

  1989cites this paper
• Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen.

  1989cites this paper
• A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.

  1989cites this paper
• Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.

  1989cites this paper
• Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

  1989cites this paper
• Weekly CHOP for the Treatment of Advanced Intermediate and High‐Grade Non‐Hodgkin's Lymphoma

  1989cites this paper
• MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study.

  1989cites this paper
• EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.

  1989cites this paper
• Radiolabeled monoclonal antibodies against Reed-Sternberg cells for in vivo imaging of Hodgkin's disease by immunoscintigraphy.

  1989cites this paper
• Interpretation of clinical trials in diffuse large-cell lymphoma.

  1988cites this paper